150 related articles for article (PubMed ID: 24579036)
1. Neo-adjuvant hormonal treatment for the undescendent testis - a benefit for the patient?
Stein R
Cent European J Urol; 2013; 66(2):229-31. PubMed ID: 24579036
[No Abstract] [Full Text] [Related]
2. Neo-adjuvant hormonal therapy.
Valenzuela M; Julian TB
Breast J; 2008; 14(3):279-83. PubMed ID: 18373643
[TBL] [Abstract][Full Text] [Related]
3. Metachronous tumors of testis in undescendent and ectopic testis.
Ozbey I; Aksoy Y; Polat O; Gündoğdu C; Biçgi O
Int Urol Nephrol; 2001; 33(3):525-8. PubMed ID: 12230288
[No Abstract] [Full Text] [Related]
4. Heterotopic adrenal gland in undescendent testis - Case report.
Anakievski D; Malinova D
Urol Case Rep; 2019 Nov; 27():101008. PubMed ID: 31641595
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Role of Tumor Budding in Breast Cancer Patients Receiving Neo-Adjuvant Therapy.
Mozarowski P; Rasaiah B; Reed M; Lewis A; Walde N; Voutsadakis IA
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33670512
[TBL] [Abstract][Full Text] [Related]
6. Overuse of Neo-adjuvant Chemotherapy for Primary Breast Cancer.
Wadhwani N; Jatoi I
Indian J Surg Oncol; 2020 Mar; 11(1):12-14. PubMed ID: 32205961
[TBL] [Abstract][Full Text] [Related]
7. [Non palpable testis in adult: laparoscopic treatment].
Liverani A; Conte S; Marino G; Mari FS; Milillo A; Pezzatini M
G Chir; 2007; 28(8-9):344-6. PubMed ID: 17785051
[TBL] [Abstract][Full Text] [Related]
8. Depression related to (neo)adjuvant hormonal therapy for prostate cancer.
van Tol-Geerdink JJ; Leer JW; van Lin EN; Schimmel EC; Stalmeier PF
Radiother Oncol; 2011 Feb; 98(2):203-6. PubMed ID: 21256610
[TBL] [Abstract][Full Text] [Related]
9. Neo-adjuvant chemotherapy for advanced stage endometrial carcinoma: a glimmer of hope in select patients.
Rabinovich A
Arch Gynecol Obstet; 2016 Jan; 293(1):47-53. PubMed ID: 26288978
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0).
Deo SV; Bhutani M; Shukla NK; Raina V; Rath GK; Purkayasth J
J Surg Oncol; 2003 Dec; 84(4):192-7. PubMed ID: 14756429
[TBL] [Abstract][Full Text] [Related]
11. The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator.
Ayez N; van der Stok EP; Grünhagen DJ; Rothbarth J; van Meerten E; Eggermont AM; Verhoef C
Eur J Surg Oncol; 2015 Jul; 41(7):859-67. PubMed ID: 25979624
[TBL] [Abstract][Full Text] [Related]
12. Neo-adjuvant hormonotherapy does not facilitate radical prostatectomy.
Van Poppel H; Ameye F; Oyen R; Van De Voorde W; Baert L
Acta Urol Belg; 1992; 60(3):73-82. PubMed ID: 1492636
[TBL] [Abstract][Full Text] [Related]
13. Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer.
Lamb DS; Denham JW; Mameghan H; Joseph D; Turner S; Matthews J; Franklin I; Atkinson C; North J; Poulsen M; Kovacev O; Robertson R; Francis L; Christie D; Spry NA; Tai KH; Wynne C; Duchesne G
Radiother Oncol; 2003 Sep; 68(3):255-67. PubMed ID: 13129633
[TBL] [Abstract][Full Text] [Related]
14. Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.
Ayez N; van der Stok EP; de Wilt H; Radema SA; van Hillegersberg R; Roumen RM; Vreugdenhil G; Tanis PJ; Punt CJ; Dejong CH; Jansen RL; Verheul HM; de Jong KP; Hospers GA; Klaase JM; Legdeur MC; van Meerten E; Eskens FA; van der Meer N; van der Holt B; Verhoef C; Grünhagen DJ
BMC Cancer; 2015 Mar; 15():180. PubMed ID: 25884448
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous PET/MRI assessment of response to cytotoxic and hormone neo-adjuvant chemotherapy in breast cancer: a preliminary report.
Romeo V; D'Aiuto M; Frasci G; Imbriaco M; Nicolai E
Med Oncol; 2017 Feb; 34(2):18. PubMed ID: 28035580
[TBL] [Abstract][Full Text] [Related]
16. The risk of malignancy in the surgical margin at radical prostatectomy reduced almost three-fold in patients given neo-adjuvant hormone treatment.
Hugosson J; Abrahamsson PA; Ahlgren G; Aus G; Lundberg S; Schelin S; Schain M; Pedersen K
Eur Urol; 1996; 29(4):413-9. PubMed ID: 8791047
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Neo-Adjuvant Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma: A PRISMA-Compliant Meta-Analysis and Systematic Review.
Liu W; Fu XL; Yang JY; Liu DJ; Li J; Zhang JF; Huo YM; Yang MW; Hua R; Sun YW
Medicine (Baltimore); 2016 Apr; 95(15):e3009. PubMed ID: 27082545
[TBL] [Abstract][Full Text] [Related]
18. Expression of p53 and bcl-2 in clinically localized prostate cancer before and after neo-adjuvant hormonal therapy.
Cesinaro AM; Migaldi M; Ferrari G; Castagnetti G; Dotti A; De Gaetani C; Ferrari P; Trentini GP
Oncol Res; 2000; 12(1):43-9. PubMed ID: 11061345
[TBL] [Abstract][Full Text] [Related]
19. Effect of adjuvant chemotherapy on recurrence-free survival varies by neo-adjuvant treatment in patients with stage III rectal cancer.
van Erning FN; Rutten HJ; van den Berg HA; Lemmens VE; van Halteren HK
Eur J Surg Oncol; 2015 Dec; 41(12):1630-5. PubMed ID: 26437853
[TBL] [Abstract][Full Text] [Related]
20. A minimum yield of twelve lymph nodes in rectal cancer remains valid in the era of neo-adjuvant treatment : results from a national cohort study.
Lykke J; Jess P; Roikjaer O;
Int J Colorectal Dis; 2015 Mar; 30(3):347-51. PubMed ID: 25652878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
